SIRI as a biomarker for bladder neoplasm: Utilizing decision curve analysis to evaluate clinical net benefit
Pierluigi Russo(Università Cattolica del Sacro Cuore), Bernardo Rocco(Università Cattolica del Sacro Cuore), Nazario Foschi(Agostino Gemelli University Polyclinic), Filippo Marino(Università Cattolica del Sacro Cuore), Chiara Ciccarese(Agostino Gemelli University Polyclinic), Mauro Ragonese(Agostino Gemelli University Polyclinic), C. Gandi(Agostino Gemelli University Polyclinic), Marco Racioppi(Università Cattolica del Sacro Cuore), Giovanni Battista Filomena(Università Cattolica del Sacro Cuore), Emilio Sacco(Agostino Gemelli University Polyclinic), Roberto Iacovelli(Agostino Gemelli University Polyclinic), Filippo Gavi(Università Cattolica del Sacro Cuore), Giuseppe Palermo(Agostino Gemelli University Polyclinic), Maria Chiara Sighinolfi(Agostino Gemelli University Polyclinic), Savio Domenico Pandolfo(University of Salerno), Giuseppe Maioriello(Agostino Gemelli University Polyclinic), Francesco Pio Bizzarri(Università Cattolica del Sacro Cuore), Nicolò Lentini(Università Cattolica del Sacro Cuore), Stefano Moretto(Humanitas University)
Urologic Oncology Seminars and Original Investigations
February 11, 2025
Cited by 31
Related Papers
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
|European Urology|2020|313
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
|Biomedicines|2023|161
Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study
|Journal of Clinical Medicine|2021|131
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
|Journal of Clinical Medicine|2023|129